Statins for Graves' orbitopathy (STAGO): a phase 2, open-label, adaptive, single centre, randomised clinical trial - The Lancet Diabetes & Endocrinology
Por um escritor misterioso
Descrição
Simvastatin downregulates adipogenesis in 3T3-L1 preadipocytes and
Lancet子刊：万能药他汀又来了，甲亢突眼它也能治！@MedSci
Rosuvastatin in the Primary Prevention of Cardiovascular Disease
Current concepts regarding Graves' orbitopathy - Bartalena - 2022
Sherita Hill Golden: tackling the source of health disparities
Statins and type 2 diabetes: genetic studies on target - The Lancet
Proposal for Standardization of Primary and Secondary Outcomes in
PDF) Application and impact assessment of an interactive journal
Rosuvastatin in the Primary Prevention of Cardiovascular Disease
Rosuvastatin in the Primary Prevention of Cardiovascular Disease
Effect of dapagliflozin on the rate of decline in kidney function
Rosuvastatin in the Primary Prevention of Cardiovascular Disease
Statins improve Graves' orbitopathy in active eye disease with
